Results from two early-phase trials presented at the American Society of Clinical Oncology suggest that an immunotherapy using genetically engineered immune cells may be effective in patients with advanced multiple myeloma.
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2sjYS0K
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου